Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank67
Studio
Year-over-Year Change

Year-over-year net income growth rate

Latest
-42.37%
↑ 57% vs avg
Percentile
P67
Within normal range
Streak
2 yr
Consecutive growthAccelerating
Average
-98.51%
Historical baseline
PeriodValue
2025-42.37%
2024-125.11%
2023-226.57%
20220.00%